Suppr超能文献

长链非编码RNA和环状RNA在宫颈癌中的作用:调节miRNA功能

The role of long non-coding RNAs and circular RNAs in cervical cancer: modulating miRNA function.

作者信息

Heidari-Ezzati Sama, Moeinian Parisa, Ahmadian-Nejad Bahar, Maghbbouli Faezeh, Abbasi Sheida, Zahedi Mahlagha, Afkhami Hamed, Shadab Alireza, Sajedi Nayereh

机构信息

School of Nursing and Midwifery, Bonab University of Medical Sciences, Bonab, Iran.

Department of Medical Genetics and Molecular Biology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

出版信息

Front Cell Dev Biol. 2024 Feb 16;12:1308730. doi: 10.3389/fcell.2024.1308730. eCollection 2024.

Abstract

Cervical cancer (CC) is a primary global health concern, ranking as the fourth leading cause of cancer-related death in women. Despite advancements in prognosis, long-term outcomes remained poor. Beyond HPV, cofactors like dietary deficiencies, immunosuppression, hormonal contraceptives, co-infections, and genetic variations are involved in CC progression. The pathogenesis of various diseases, including cancer, has brought to light the critical regulatory roles of microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs). The aberrant expression of these miRNAs, lncRNAs, and circRNAs plays a pivotal role in the initiation and progression of CC. This review provides a comprehensive summary of the recent literature regarding the involvement of lncRNAs and circRNAs in modulating miRNA functions in cervical neoplasia and metastasis. Studies have shown that lncRNAs and circRNAs hold great potential as therapeutic agents and innovative biomarkers in CC. However, more clinical research is needed to advance our understanding of the therapeutic benefits of circRNAs and lncRNAs in CC.

摘要

宫颈癌(CC)是全球主要的健康问题,是女性癌症相关死亡的第四大主要原因。尽管预后有所改善,但长期结果仍然不佳。除了人乳头瘤病毒(HPV)外,饮食缺乏、免疫抑制、激素避孕药、合并感染和基因变异等辅助因素也与宫颈癌的进展有关。包括癌症在内的各种疾病的发病机制揭示了微小RNA(miRNA)、长链非编码RNA(lncRNA)和环状RNA(circRNA)的关键调节作用。这些miRNA、lncRNA和circRNA的异常表达在宫颈癌的发生和发展中起关键作用。本综述全面总结了近期有关lncRNA和circRNA参与调节宫颈癌形成和转移中miRNA功能的文献。研究表明,lncRNA和circRNA在宫颈癌中作为治疗剂和创新生物标志物具有巨大潜力。然而,需要更多的临床研究来加深我们对circRNA和lncRNA在宫颈癌治疗益处的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444e/10906305/dcc0c790da3d/FCELL_fcell-2024-1308730_wc_abs.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验